Risk Of Developing Liver Cancer After HCV Treatment

Tuesday, November 8, 2016

Watch - An Introduction to Access to Generic Hepatitis C Medicines



World Hepatitis Alliance

Published on Nov 2, 2016
Following the success of the first two webinars in the Knowledge for Change series covering access to diagnostics and medicines, we were pleased to deliver the next in the series, ‘An Introduction to Accessing Generic Hepatitis C Medicines’ on 1 November. The webinar explored the generics landscape for hepatitis C with discussions on legalities, quality and performance of generics medicines as well as providing examples of how people across the globe are accessing them.

Chair: Raquel Peck, CEO, World Hepatitis Alliance

Panellists:
- Andrew Hill, Senior Visiting Research Fellow, Department of Pharmacology, University of Liverpool
- Giten Khwairakpam, Project Manager for Community and Policy, TREAT Asia
- Erika Duenas, Advocacy Officer, Medicines Patent Pool


No comments:

Post a Comment